PO.MCB09.04 · 分子与细胞生物学
膳食纤维摄入改变DIET试验中的胆汁酸代谢谱——一项在接受免疫治疗的黑色素瘤患者中进行的随机双盲膳食干预研究
Dietary fiber intake modifies the bile acid metabolic profile in the DIET trial - A randomized double blinded dietary intervention study in melanoma patients receiving immunotherapy
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:膳食纤维与黑色素瘤对免疫检查点阻断(ICB)的反应相关。我们此前开展了DIET试验(NCT04645680),这是一项完全对照的喂养研究,在接受ICB的黑色素瘤患者中比较高纤维饮食与健康对照饮食。该试验显示高纤维饮食可行且安全,采用高纤维饮食的患者表现出数值上更高的反应率。在此,我们报告膳食干预对全身代谢影响这一次要目标。
方法:开始ICB的黑色素瘤患者(n=45)在1周平衡期后按2:1随机分组,在研究期间(最多10周)接受高纤维饮食(通过天然食物每两周递增的30 g/d纤维,最高至50 g/d)或健康对照饮食(20 g/d纤维)。在基线和每次输注时(如在当地接受治疗)纵向采集血样,最多持续三个周期。来自43名患者的血清使用LC-MS/MS方法进行非靶向代谢组学和胆汁酸(BA)分析。当前分析聚焦于比较高纤维组(n=6)和对照组(n=8)患者在平衡期与第1-4周采集的配对样本,反映高纤维组每日30-40 g的膳食纤维。
结果:非靶向代谢组学分析显示,与对照组相比,高纤维组中BA以及甘氨酸和牛磺酸结合衍生物的变化有所减少(Wilcoxon秩和检验p<0.05)。靶向BA分析证实了非结合型次级BA以及次级与初级BA比值的下降,这可能影响抗肿瘤免疫。具体而言,我们的发现提示膳食纤维减少了由肠道微生物群介导的从初级BA(胆酸和鹅去氧胆酸)到次级BA(脱氧胆酸、石胆酸和熊去氧胆酸)的生物转化。高纤维组中结合型与非结合型BA的比值也下降,提示肝脏BA结合可能减少。此外,在黑色素瘤小鼠avatar模型中,使用来自DIET试验参与者的配对粪便标本(高纤维饮食前vs后)进行粪便微生物群移植。与高纤维饮食前的受体相比,高纤维饮食后的受体(n=5)表现出改善的ICB反应和循环中次级与初级BA比值的下降。
结论:与既往其他背景下的对照喂养研究一致,我们来自循环代谢物的综合发现提示,膳食纤维干预调节了与ICB反应相关的微生物组介导的次级BA合成和结合。这些发现值得在临床前模型和更大患者队列中进行进一步的机制研究。
查看英文原文 English abstract
Background: Dietary fiber is associated with response to immune checkpoint blockade (ICB) in melanoma. We previously conducted the DIET trial (NCT04645680) which was a fully controlled feeding study comparing a high fiber versus a healthy control diet in melanoma patients receiving ICB. The trial revealed that high fiber diet is feasible and safe, and patients on high fiber diet demonstrated a numerically higher response rate. Herein, we report a secondary objective of the effects of dietary intervention on systemic metabolism.
Methods: Melanoma patients (n=45) initiating ICB were randomized (2:1), following a 1-week equilibration, to either a high fiber (30 g/d fiber ramped-up biweekly via whole foods to 50 g/d) or a healthy control diet (20 g/d fiber) for the study duration (up to 10 weeks). Longitudinal blood specimens were collected at baseline and at each infusion (when treated locally) for up to three cycles during the study. Sera from 43 patients were processed for untargeted metabolomics and bile acid (BA) profiling using LC-MS/MS methods. Current analysis focuses on comparison of paired samples from patients in the high fiber (n=6) and the control arm (n=8) collected during equilibration vs week 1-4, reflecting a dietary fiber 30-40 g/day in the high fiber arm.
Results: The untargeted metabolomics analyses revealed changes in BAs and glycine- and taurine- conjugated derivates to be reduced in the high fiber arm compared to control (Wilcoxon rank sum test p<0.05). Targeted BA profiling confirmed a decrease in unconjugated secondary BAs and secondary-to-primary BA ratios, which may influence anti-tumor immunity. Specifically, our findings suggest that dietary fiber reduced gut microbiota mediated biotransformation of secondary BAs (deoxycholic acid, lithocholic acid and ursodeoxycholic acid) from primary BAs (cholic acid and chenodeoxycholic acid). Conjugated to unconjugated BA ratios were also decreased in the high fiber arm, suggesting potentially reduced hepatic BA conjugation. Furthermore, in mouse avatar models of melanoma, fecal microbiota transplant was performed using paired fecal specimens (pre vs post high fiber diet) from participants in the DIET trial. Post-high fiber diet recipients showed improved ICB response and decreased secondary-to-primary BA ratios in the circulation (n=5) compared to pre-high fiber diet recipients.
Conclusion: Consistent with prior controlled feeding studies in other settings, our collective findings from circulating metabolites suggested that dietary fiber intervention modulates microbiome mediated secondary BA synthesis and conjugation linked to ICB response. These findings warrant further mechanistic studies in preclinical models and in larger cohort of patients.
利益披露 Disclosure
Y. Jiang, None..
J. Fahrmann, None..
E. Irajizad, None..
S. Saha, None..
N. Dizman, None..
C. B. Peterson, None..
E. M. Burton, None..
M. A. Davies, None..
N. J. Ajami, None.